Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
Medical isotopes
Nordion reaches settlement with AECL to resolve isotope supply agreement
Medical isotopes : 21 August, 2013
Nordion has entered into a comprehensive settlement agreement with Atomic Energy of Canada Limited (AECL) to resolve the outstanding claims between both parties related to the MAPLE facilities.
PETNET Solutions signs EU manufacturing agreement with Lilly for Amyvid radiopharmaceutical
Medical isotopes : 04 June, 2013
PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, is to begin manufacturing Eli Lilly's Amyvid(Florbetapir (18F)) radiopharmaceutical in the United Kingdom, as well as in Spain and France, after signing a manufacturing services agreement with Eli Lilly.
Lantheus Medical Imaging signs Mo-99 supply contract deal with Institute for Radioelements
Medical isotopes : 21 March, 2013
Lantheus Medical Imaging agrees a new supply contract with the Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for use in its TechneLite (Technetium Tc 99m Generator) generators.
Endomagnetics is pinpointed as a future star business
Medical isotopes : 19 November, 2012
The Real Business Future 50 project selects Endomagnetics, the company developing a portfolio of products to improve the standard of breast cancer management, as one of the UK's most exciting, high-potential new businesses.
Lantheus Medical Imaging extends Mo-99 contract with NTP Radioisotopes
Medical isotopes : 01 November, 2012
Lantheus Medical Imaging agrees to work with two world leaders in producing medical isotopes to help ensure supplies of potentially life-saving nuclear medicine using molybdenum-99 (Mo-99) sourced from Low Enriched Uranium (LEU).
Nordion extends Mo-99 supply deal with Lantheus Medical Imaging through 2015
Medical isotopes : 23 October, 2012
Nordion is extending the company's contract with its primary Medical Isotopes customer, Lantheus Medical Imaging (LMI) for the supply of Molybdenum-99 (Mo-99).
Cardinal Health unveils new nuclear medicine technology enhancements
Medical isotopes : 11 June, 2012
Cardinal Health is introducing new technology enhancements that make it possible for hospital nuclear medicine departments and imaging centres to seamlessly improve data integration and the overall efficiency of their operations.
Nordion signs six-year Cobalt-60 supply deal With Synergy Health
Medical isotopes : 23 January, 2012
Nordion signs a six-year contract to supply cobalt-60 to Synergy Health, a leading international contract sterilization service company headquartered in the United Kingdom.
MD Anderson Cancer Center orders Cesium-131 for cancer study
Medical isotopes : 11 October, 2011
MD Anderson Cancer Center initiates orders of Cesium-131 brachytherapy (internal radiation therapy) seeds from IsoRay as it continues the centre's clinical research study investigating brachytherapy's ability to help control intermediate risk prostate cancer.
Nordion divests several Belgian operations to Best Medical
Medical isotopes : 04 April, 2011
Best Medical acquires all shares of MDS Nordion SA, located in Fleurus, Belgium. Best Medical will be operating three of the four Belgian lines of business:
US FDA approves use of Mo-99 in the production of Tc-99m generators
Medical isotopes : 14 March, 2011
The US Food and Drug Administration (FDA) approves the use of molybdenum-99 (Mo-99) derived from low-enriched uranium (LEU) in the production of technetium-99m (Tc-99m) generators.
Lantheus Medical Imaging extends Mo-99 isotope deal with Nordion to 2013
Medical isotopes : 07 January, 2011
Lantheus Medical Imaging is extending its contract with Nordion through to 2013 for the continued supply of molybdenum-99 (Mo-99).
MDS Nordion signs Mo-99 supply deal with Lantheus Medical Imaging
Medical isotopes : 12 July, 2010
MDS Nordion signs a new contract with its primary customer, Lantheus Medical Imaging for the supply of Molybdenum-99 (Mo-99).
Ubichem Research is approved to supply cGMP radiolabelled APIs
Medical isotopes : 02 June, 2010
Ubichem, through its Hungarian operation – Ubichem Research - completes a regulatory inspection and is now approved for the supply of cGMP radiolabelled Active Pharmaceutical Ingredients (APIs).
Covidien agrees Polish source for Mo 99 and Tc 99m medical isotopes
Medical isotopes : 22 February, 2010
Covidien and the Institute of Atomic Energy in Poland (IAE POLATOM) sign an agreement to augment and further diversify Covidien's supply of Molybdenum 99 (Mo 99) to produce the medical isotope Technetium 99m (Tc 99m).
MDS Nordion starts production of Rubidium-82 generators for Bracco Diagnostics
Medical isotopes : 11 June, 2009
MDS Nordion is commencing the manufacture of CardioGen-82 (Rubidium-82 generators), for Bracco Diagnostics (part of Bracco Group), one of the world's leading companies in the imaging agent business.
MDS Nordion opens radiopharmaceutical production facility for PET imaging
Medical isotopes : 01 June, 2009
MDS Nordion opens a facility in Fleurus, Belgium for the production of Glucotrace (Fluorodeoxyglucose), a radiopharmaceutical used in positron emission tomography (PET) imaging.
Cardinal Health supports advance medical imaging investment in Ohio
Medical isotopes : 01 May, 2009
The Ohio State University, Cardinal Health and Ohio Third Frontier are collaborating to invest more than $10 million to help shape the future of the medical diagnostic industry by combining Ohio State's Wright Center of Innovation in Biomedical Imaging research capabilities and Cardinal Health's manufacturing and commercialization expertise for molecular imaging agents.
Cardinal Health opens radiopharmaceuticals production facility in Nebraska, USA
Medical isotopes : 18 March, 2009
Cardinal Health opens a new facility in Omaha, Nebraska, USA, that manufactures radiopharmaceuticals, which gives local physicians new tools that aid in the early diagnosis and treatment of disease.
MDS Nordion launches improved administration system for Y-90 radiation therapy
Medical isotopes : 10 March, 2009
MDS Nordion has launched an improved administration system for TheraSphere, Yttrium-90 Microsphere (Y-90), a targeted internal radiation therapy for patients with inoperable, primary liver cancer.
Covidien collaborates with B and W to produce more Mo-99 isotope
Medical isotopes : 26 January, 2009
Covidien has signed an agreement with Babcock and Wilcox Technical Services Group to develop technology for the manufacture of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), the most widely used radioisotope in the world for molecular imaging and nuclear medicine procedures.
PETNET Solutions achieves 98.8 percent delivery rate for radioactive isotopes
Medical isotopes : 25 September, 2008
A division of Siemens, PETNET Solutions, has reported a 98.8 percent success rate in the production and delivery of its radioactive isotopes.
Cardinal Health support clinical drug trials by expanding PET Nuclear Pharmacy Services
Medical isotopes : 17 June, 2008
Cardinal Health is to begin manufacturing, compounding and distributing Positron Emission Tomography (PET) radiopharmaceuticals for clinical trials.
GE Healthcare is appointed to distribute Draximage Sestamibi in the USA
Medical isotopes : 21 December, 2007
Draximage, the radiopharmaceutical division of Draxis Health, has appointed GE Healthcare as the exclusive distributor of the Draximage Sestamibi kit in the USA.
MDS Nordion divests external beam therapy products to Best Medical International
Medical isotopes : 30 November, 2007
MDS Nordion has signed an agreement with Best Medical International to divest its external beam therapy and self-contained irradiator product lines.
MDS Nordion secures cobalt-60 supply through 17 year contract with Rosenergoatom
Medical isotopes : 19 October, 2007
MDS Nordion has signed a 17 year cobalt-60 supply contract with Rosenergoatom, the operating utility of Russia's nuclear power plants.
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo